Correlation Between Alkame Holdings and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alkame Holdings and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkame Holdings and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alkame Holdings and Aerovate Therapeutics, you can compare the effects of market volatilities on Alkame Holdings and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkame Holdings with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkame Holdings and Aerovate Therapeutics.
Diversification Opportunities for Alkame Holdings and Aerovate Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alkame and Aerovate is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Alkame Holdings and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Alkame Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkame Holdings are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Alkame Holdings i.e., Alkame Holdings and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Alkame Holdings and Aerovate Therapeutics
If you would invest 253.00 in Aerovate Therapeutics on September 16, 2024 and sell it today you would earn a total of 0.00 from holding Aerovate Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Alkame Holdings vs. Aerovate Therapeutics
Performance |
Timeline |
Alkame Holdings |
Aerovate Therapeutics |
Alkame Holdings and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alkame Holdings and Aerovate Therapeutics
The main advantage of trading using opposite Alkame Holdings and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkame Holdings position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Alkame Holdings vs. Hill Street Beverage | Alkame Holdings vs. Flow Beverage Corp | Alkame Holdings vs. Eq Energy Drink | Alkame Holdings vs. V Group |
Aerovate Therapeutics vs. Puma Biotechnology | Aerovate Therapeutics vs. Iovance Biotherapeutics | Aerovate Therapeutics vs. Zentalis Pharmaceuticals Llc | Aerovate Therapeutics vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |